Traditional analysis
Carnegie, Erik Hultgård, +46 8 588 687 43
Commissioned analysis
Erik Penser Bank, Sweden, Klas Palin
+46 (0)73 261 82 60
Read initiating report
Redeye, Sweden, Ethel Luvall
+46 (0)76 492 50 95
Read the latest Report
Orexo has decided to terminate the contract with Redeye, which will be effective as of December 21, 2022
RX Securities, London, UK, Dr Samir Devani
+44 (0)20 7993 8210
E-mail: info@rxsecurities.com
The report is only available for institutional investors